... "The moment I received my official diagnosis, I dropped all my assumptions about HIV. It was so freeing." -Member of myHIVteamLiving with a chronic condition can be difficult and even a burden, but also an opportunity to rid yourself of what you think you know. Have you heard the saying, "People don't get it until they get it"? ...
Beginner's Mind - Not Knowing It All When Living with HIV
... "The moment I received my official diagnosis, I dropped all my assumptions about HIV. It was so freeing." -Member of myHIVteamLiving with a chronic condition can be difficult and even a burden, but also an opportunity to rid yourself of what you think you know. Have you heard the saying, "People don't get it until they get it"? ...
... Does your doctor closely monitor your blood pressure? Share in the comments below. ...
... That being said, many of my feelings and thoughts were directed toward my value and dignity as a human being. Looking back now, after 18 years of living with HIV, I say to myself, “What a wonderful human being I am. What a good person I am, with dignity and self-worth. ...
An HIV Diagnosis — and Journey to Acceptance
... That being said, many of my feelings and thoughts were directed toward my value and dignity as a human being. Looking back now, after 18 years of living with HIV, I say to myself, “What a wonderful human being I am. What a good person I am, with dignity and self-worth. ...
... and Delivery of Emotional Support To Promote Linkage and Engagement in HIV Care — Patient Preference and Adherence Tips for Talking With a Health Care Provider About Your Mental Health — National Institute of Mental Health Psychosocial Well-Being and HIV-Related Immune Health Outcomes Among HIV-Positive Older Adults: Support for a Biopsychosocial Model ...
5 Ways To Receive Emotional Support With HIV
... and Delivery of Emotional Support To Promote Linkage and Engagement in HIV Care — Patient Preference and Adherence Tips for Talking With a Health Care Provider About Your Mental Health — National Institute of Mental Health Psychosocial Well-Being and HIV-Related Immune Health Outcomes Among HIV-Positive Older Adults: Support for a Biopsychosocial Model ...
... — HIV.gov HIV-1 and HIV-2 — Aidsmap HIV-2 Infection — StatPearls HIV-1 Subtypes — Aidsmap Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV — Clinicalinfo.HIV.gov HIV/AIDS — Mayo Clinic HIV-2 as a Model To Identify a Functional HIV Cure — AIDS Research and Therapy Plasma Viral Load in HIV-1 and HIV-2 Singly and Dually ...
HIV-1 vs. HIV-2: What Are The Differences and Can You Have Both?
... — HIV.gov HIV-1 and HIV-2 — Aidsmap HIV-2 Infection — StatPearls HIV-1 Subtypes — Aidsmap Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV — Clinicalinfo.HIV.gov HIV/AIDS — Mayo Clinic HIV-2 as a Model To Identify a Functional HIV Cure — AIDS Research and Therapy Plasma Viral Load in HIV-1 and HIV-2 Singly and Dually ...
... Food and Drug Administration, news release, March 5, 2019; National Public RadioCopyright © 2019 All rights reserved. ...
... Most people starting HIV treatment today receive a tenofovir-based combination because these are the preferred first choices.Abacavir and lamivudine are used only as an alternative for people who meet all the following criteria: Can’t take tenofovir Have no heart disease risk Test negative for the HLA-B*5701 gene Have a lower amount of virus in the ...
Abacavir and Lamivudine: Why They’re Used Together
... Most people starting HIV treatment today receive a tenofovir-based combination because these are the preferred first choices.Abacavir and lamivudine are used only as an alternative for people who meet all the following criteria: Can’t take tenofovir Have no heart disease risk Test negative for the HLA-B*5701 gene Have a lower amount of virus in the ...
... Low risk — Zidovudine treatment for two weeks Medium risk — Zidovudine treatment for four to six weeks High risk — HIV therapy with three-drug treatment from birth for two to six weeks; if less than six weeks, continued use of zidovudine alone to complete six weeks of therapy Breastfeeding In the past, health experts did not recommend that an HIV-positive ...
HIV and Pregnancy: Preventing Transmission
... Low risk — Zidovudine treatment for two weeks Medium risk — Zidovudine treatment for four to six weeks High risk — HIV therapy with three-drug treatment from birth for two to six weeks; if less than six weeks, continued use of zidovudine alone to complete six weeks of therapy Breastfeeding In the past, health experts did not recommend that an HIV-positive ...
Join
